Your browser doesn't support javascript.
loading
Variation of Genomic Sites Associated with Severe Covid-19 Across Populations: Global and National Patterns.
Balanovsky, Oleg; Petrushenko, Valeria; Mirzaev, Karin; Abdullaev, Sherzod; Gorin, Igor; Chernevskiy, Denis; Agdzhoyan, Anastasiya; Balanovska, Elena; Kryukov, Alexander; Temirbulatov, Ilyas; Sychev, Dmitriy.
Affiliation
  • Balanovsky O; Laboratory of Genome Geography, Vavilov Institute of General Genetics, Moscow, Russia.
  • Petrushenko V; Laboratory of Human Population Genetics, Research Centre for Medical Genetics, Moscow, Russia.
  • Mirzaev K; Biobank of North Eurasia, Moscow, Russia.
  • Abdullaev S; Laboratory of Genome Geography, Vavilov Institute of General Genetics, Moscow, Russia.
  • Gorin I; Department of Bioinformatics Moscow Institute of Physics and Technology, Moscow, Russia.
  • Chernevskiy D; Laboratory of Human Population Genetics, Research Centre for Medical Genetics, Moscow, Russia.
  • Agdzhoyan A; Department of Clinical Pharmacology and Therapeutics, Russian Medical Academy of Continuous Professional Education, Moscow, Russia.
  • Balanovska E; Department of Clinical Pharmacology and Therapeutics, Russian Medical Academy of Continuous Professional Education, Moscow, Russia.
  • Kryukov A; Laboratory of Genome Geography, Vavilov Institute of General Genetics, Moscow, Russia.
  • Temirbulatov I; Department of Bioinformatics Moscow Institute of Physics and Technology, Moscow, Russia.
  • Sychev D; Laboratory of Human Population Genetics, Research Centre for Medical Genetics, Moscow, Russia.
Pharmgenomics Pers Med ; 14: 1391-1402, 2021.
Article in En | MEDLINE | ID: mdl-34764675
BACKGROUND: Information about the distribution of clinically significant genetic markers in different populations may be helpful in elaborating personalized approaches to the clinical management of COVID-19 in the absence of consensus guidelines. AIM: Analyze frequencies and distribution patterns of two markers associated with severe COVID-19 (rs11385942 and rs657152) and look for potential correlations between these markers and deaths from COVID-19 among populations in Russia and across the world. METHODS: We genotyped 1883 samples from 91 ethnic groups pooled into 28 populations representing Russia and its neighbor states. We also compiled a dataset on 32 populations from other regions using genotypes extracted or imputed from the available databases. Geographic maps showing the frequency distribution of the analyzed markers were constructed using the obtained data. RESULTS: The cartographic analysis revealed that rs11385942 distribution follows the West Eurasian pattern: the marker is frequent among the populations of Europe, West Asia and South Asia but rare or absent in all other parts of the globe. Notably, the transition from high to low rs11385942 frequencies across Eurasia is not abrupt but follows the clinal variation pattern instead. The distribution of rs657152 is more homogeneous. The analysis of correlations between the frequencies of the studied markers and the epidemiological characteristics of COVID-19 in a population revealed that higher frequencies of both risk alleles correlated positively with mortality from this disease. For rs657152, the correlation was especially strong (r = 0.59, p = 0.02). These reasonable correlations were observed for the "Russian" dataset only: no such correlations were established for the "world" dataset. This could be attributed to the differences in methodology used to collect COVID-19 statistics in different countries. CONCLUSION: Our findings suggest that genetic differences between populations make a small yet tangible contribution to the heterogeneity of the pandemic worldwide.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Risk_factors_studies Language: En Journal: Pharmgenomics Pers Med Year: 2021 Document type: Article Affiliation country: Russia Country of publication: New Zealand

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline / Risk_factors_studies Language: En Journal: Pharmgenomics Pers Med Year: 2021 Document type: Article Affiliation country: Russia Country of publication: New Zealand